e8vk
 

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of earliest event reported: February 23, 2004

Select Medical Corporation

(Exact name of registrant as specified in charter)
         
Delaware   000-32499   23-2872718
(State of Incorporation)   (Commission File
Number) 		  (I.R.S. Employer
Identification No.)

4716 Old Gettysburg Road, P.O. Box 2034, Mechanicsburg, PA 17055

(Address of Principal Executive Offices) (Zip Code)

(717) 972-1100

(Registrant’s telephone number, including area code)

 

 

Item 9. Regulation FD Disclosure.

          On February 23, 2004, Select Medical Corporation issued a press release announcing the authorization of a stock repurchase program. A copy of the press release is attached as Exhibit 99.1 to this report.

          The information in this report (including Exhibit 99.1) is being furnished pursuant to Item 9 and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act.

 

 

SIGNATURE

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

         
    SELECT MEDICAL CORPORATION
         
Date: February 23, 2004   By:   /s/ Michael E. Tarvin
       
        Michael E. Tarvin
        Senior Vice President, General Counsel and
        Secretary

 

 

EXHIBIT INDEX

     
Exhibit No.   Description
 
99.1   Select Medical Corporation press release, dated February
23, 2004